Todd Kaloudis

Managing Director
Cobro Ventures Management


​

Mr. Todd Kaloudis serves as Managing Director & General Partner at Cobro Ventures. He has a 20+ year track record as an operating partner to technology CEOs, helping them grow revenue and EBITDA, lead organizational transformations, and close strategic financings. He was part of the executive teams leading go-to-market functions at OPNET Technologies (Nasdaq IPO; acquired by Riverbed Technology), Dynatrace (acquired by Thoma Bravo; merger with Keynote Systems), and Platform Science (acquisition and merger with Trimble Mobility). He currently serves on the boards of Techsomed (AI, SaaS, med tech) and AI Proteins (synthetic biology). He was also an advisor to the Chairman of Frequency Therapeutics and C4 Therapeutics, where he played a key role in private financings ahead of their successful IPOs. He took undergraduate and graduate courses in artificial intelligence at MIT, where he was inducted into the Eta Kappa Nu academic honor society.

​​
 

Speech title & Synopsis

Panel Discussion 3: MedTech & Diagnosis

as panelist